Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Tocilizumab did not reduce hypoxemic respiratory...
Journal article

Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19.

Abstract

SOURCE CITATION: Stone JH, Frigault MJ, Serling-Boyd NJ, et al. Efficacy of tocilizumab in patients hospitalized with Covid-19. N Engl J Med. 2020;383:2333-44. 33085857.

Authors

Sharif S; Rochwerg B

Journal

Annals of Internal Medicine, Vol. 174, No. 2,

Publisher

American College of Physicians

Publication Date

2 2021

DOI

10.7326/acpj202102160-016

ISSN

1056-8751